Novartis Ag NVS
NYSE NVS
$143.48 +0.77 (+0.54%)
As of: Sep 24, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Change in Intangibles (2009 - 2026)

Novartis Ag's (NVS) quarterly Change in Intangibles came in at -$437.0 million in Q2 2026, down 92.51% year-over-year from -$5.8 billion in Q2 2025, and up 5.21% quarter-over-quarter from -$461.0 million in Q1 2026.

Analysis

Novartis Ag (NVS) Change in Intangibles (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Change in Intangibles across 14 years of filings, most recently posting -$437.0 million for Q2 2026.

  • In Q2 2026, Change in Intangibles fell 92.51% year-over-year to -$437.0 million; the TTM figure through Jun 2026 stood at -$2.3 billion (down 64.39% YoY), while the FY2025 annual figure was $164.0 million, up 105.0% from the prior year.
  • Change in Intangibles came in at -$437.0 million for Q2 2026 at Novartis Ag, up from -$461.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.8 billion in Q3 2023 to a low of -$1.5 billion in Q4 2025.
  • Average Change in Intangibles over 5 years is -$185.7 million, with a median of $2.5 million recorded in 2022.
  • Year-over-year, Change in Intangibles surged 60666.67% in 2023 and sank 4064.86% in 2025.
  • Over 5 years, Change in Intangibles stood at -$192.0 million in 2022, then surged by 101.04% to $2.0 million in 2023, then soared by 1750.0% to $37.0 million in 2024, then slumped by 4064.86% to -$1.5 billion in 2025, then jumped by 70.21% to -$437.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Intangibles figures were -$437.0 million in Q2 2026, -$461.0 million in Q1 2026, and -$1.5 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -437.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 120.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -437.00 Mn
Mar 31, 2026 -461.00 Mn
Dec 31, 2025 -1.47 Bn
Sep 30, 2025 52.00 Mn
Jun 30, 2025 -227.00 Mn
Mar 31, 2025 -1.24 Bn
Dec 31, 2024 37.00 Mn
Sep 30, 2024 23.00 Mn
Jun 30, 2024 20.00 Mn
Mar 31, 2024 -929.00 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 1.82 Bn
Jun 30, 2023 -673.00 Mn
Mar 31, 2023 130.00 Mn
Dec 31, 2022 -192.00 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 127.00 Mn
Mar 31, 2022 66.00 Mn
Dec 31, 2021 84.00 Mn
Sep 30, 2021 35.00 Mn
API Access

Novartis Ag Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=NVS&period=max&api_key=YOUR_API_KEY